XETRA · MRK.DE
Merck KGaA
€150.30+€4.25 (+2.91%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
Loading market information…
FSX · PA8.F · EUR
Stock price
Quote as of Oct 29, 2026, 12:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Paion AG’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Paion AG operates as a specialized pharmaceutical entity, concentrating its efforts on creating and selling groundbreaking treatments within the realms of anesthesia, intensive care, and critical care medicine. The company places particular importance on quickly-acting sedatives and other hospital-specific items.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€150.30+€4.25 (+2.91%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
HK$21.12-HK$0.04 (-0.19%)
HUTCHMED (China) Limited’s quoted price sits in the upper half of its reported 52-week range, 17.44% below the high.
CA$12.13+CA$0.22 (+1.85%)
Curaleaf Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.07% below the high.
$38.86+$0.98 (+2.59%)
Phibro Animal Health Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.32% below the high.
CA$3.68-CA$0.06 (-1.6%)
Tilray Brands, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.94% below the high.
CA$0.94-CA$0.01 (-1.05%)
Canopy Growth Corporation’s quoted price sits in the lower half of its reported 52-week range, 71.34% below the high.
CA$5.74+CA$0.03 (+0.53%)
Aurora Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.4% below the high.
$0.00$0.00 (0.0%)
Cannabis Global Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
